These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29607298)

  • 1. Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.
    Rössle M; Schultheiss M
    J Transl Int Med; 2018 Mar; 6(1):11-15. PubMed ID: 29607298
    [No Abstract]   [Full Text] [Related]  

  • 2. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.
    Northup PG; Davis JPE
    J Transl Int Med; 2018 Mar; 6(1):1-5. PubMed ID: 29607296
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver imaging. A hepatologist's perspective.
    Reddy SI; Grace ND
    Clin Liver Dis; 2002 Feb; 6(1):297-310, ix. PubMed ID: 11933595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: a hepatologist's approach to an infectious disease.
    Rosenberg PM
    Clin Infect Dis; 2001 Nov; 33(10):1728-32. PubMed ID: 11595980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective.
    Mancuso A
    J Transl Int Med; 2017 Dec; 5(4):194-199. PubMed ID: 29340275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.
    Khan F; Mehrzad H; Tripathi D
    J Transl Int Med; 2018 Sep; 6(3):97-104. PubMed ID: 30425945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.
    Méndez-Sánchez N; Valencia-Rodríguez A; Qi X; Yoshida EM; Romero-Gómez M; George J; Eslam M; Abenavoli L; Xie W; Teschke R; Carrion AF; Keaveny AP
    J Clin Transl Hepatol; 2020 Jun; 8(2):0024. PubMed ID: 32309152
    [No Abstract]   [Full Text] [Related]  

  • 8. A hepatologist's perspective on the management of coagulation disorders before liver transplantation.
    Everson GT
    Liver Transpl Surg; 1997 Nov; 3(6):646-52. PubMed ID: 9404970
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of interferon therapy for chronic hepatitis C: a hepatologist's perspective.
    Davis GL; Lim H
    Infect Agents Dis; 1993 Jun; 2(3):150-4. PubMed ID: 8173785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Impact of portal vein thrombosis on the efficacy of endoscopic treatment in preventing re-bleeding from ruptured gastroesophageal varices in hepatitis B-related liver cirrhosis].
    Huang XQ; Ni LY; Jiang SY; Xia RQ; Ma LL; Wang J; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):747-752. PubMed ID: 33053974
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
    J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma from a Hepatologist's Perspective.
    Roldan GA; Blomker J; Aby ES
    Semin Intervent Radiol; 2023 Dec; 40(6):524-535. PubMed ID: 38274218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: portal vein thrombosis in cirrhosis.
    Tsochatzis EA; Senzolo M; Germani G; Gatt A; Burroughs AK
    Aliment Pharmacol Ther; 2010 Feb; 31(3):366-74. PubMed ID: 19863496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
    Intagliata NM; Caldwell SH; Tripodi A
    Gastroenterology; 2019 May; 156(6):1582-1599.e1. PubMed ID: 30771355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complexities and challenges in the management of portal vein thrombosis in cirrhosis].
    Chu HK; Chen LY; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):196-198. PubMed ID: 33902183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to different thrombolysis techniques and timing of thrombolysis in the management of portal vein thrombosis in cirrhotic patients.
    Primignani M; Tosetti G; Ierardi AM
    J Transl Int Med; 2023 Sep; 11(3):198-202. PubMed ID: 37662891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
    Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
    Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Portal vein thrombosis in patients with cirrhosis].
    Dupuis M; Spahr L; Giostra E; Elkrief L
    Rev Med Suisse; 2017 Aug; 13(572):1470-1473. PubMed ID: 28853803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult living donor liver transplantation: the hepatologist's perspective.
    Schiano TD; Kim-Schluger L; Gondolesi G; Miller CM
    Hepatology; 2001 Jan; 33(1):3-9. PubMed ID: 11124813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.